Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Cryselle (Norgestrel & Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg, respectively, Duramed ANDA 75-840 Lo/Ovral & Lo/Ovral-28 (Noregestrel/Ethinyl Estradiol) Tablets & Nordette-21 & 28 (Levonorgetsrel/Ethinyl Estradiol) Tablets, Wyeth Ayerst NDA 17-612/S31, 17-802/S18, 18-668/S30, & 18-782/S23 Ogestrel 0.5/50-21 and Ogestrel 0.5/50-28 Tablets (Norgestrel and Ethinyl Estradiol Tablets USP, 0.5 mg and 0.05 mg, respectively) SCS ANDA 75-406 Ovral (norgestrel and ethinyl estradiol), Ovral-28 (norgestrel and ethinyl estradiol). Wyeth-Ayerst NDA 16-672/S-046 & 16-806/S-028 Overette (norgestrel) Tablets, Wyeth Pharmaceutical, Labeling Revision Check the most up-to-date list of FDA Approvals.                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2009 Betterchem.com